Filter
746
Filtered Results: 746
Text search:
antimalarial
drugs
Featured
Recommendations
76
New Publications
258
Language
Document type
No document type
417
Studies & Reports
109
Guidelines
96
Manuals
42
Strategic & Response Plan
26
Training Material
22
Fact sheets
17
Resource Platforms
5
Situation Updates
4
Infographics
3
Brochures
2
App
2
Videos
1
Countries / Regions
Uganda
41
Global
39
India
38
Sierra Leone
31
Kenya
30
Nigeria
26
Ghana
24
Ethiopia
23
Liberia
23
Malawi
21
Tanzania
20
Rwanda
17
Africa
16
Zambia
16
Latin America and the Carribbean
14
Nepal
12
Senegal
12
Cameroon
9
Philippines
8
South Africa
8
Namibia
8
Zimbabwe
7
Cambodia
7
Bangladesh
7
Myanmar / Burma
7
Burkina Faso
6
Mozambique
6
South–East Asia Region
6
Thailand
5
Vietnam
5
Indonesia
5
Asia
4
Congo, Democratic Republic of
4
Laos
3
Western and Central Europe
3
North America
3
East and Southern Africa
3
Papua New Guinea
3
Brazil
3
Central African Republic
3
Botswana
3
South Sudan
3
Eswatini/ Swaziland
3
China
2
Guinea
2
Haiti
2
Venezuela
2
West and Central Africa
2
Middle East and North Africa
2
Chad
2
Somalia
2
Pakistan
2
Switzerland
1
Colombia
1
Timor Leste/ East Timor
1
El Salvador
1
Lesotho
1
Turkey
1
Benin
1
Gambia
1
Togo
1
Chile
1
Burundi
1
Peru
1
Dominican Republic
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Turkmenistan
1
France
1
Southern Africa
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Belize
1
Costa Rica
1
Oman
1
Panama
1
Argentina
1
Lebanon
1
Eastern Europe
1
Nicaragua
1
Sri Lanka
1
Sudan
1
Honduras
1
Mali
1
Libya
1
Solomon Islands
1
Guatemala
1
Authors & Publishers
Publication Years
Category
Countries
405
Clinical Guidelines
72
Women & Child Health
46
Public Health
33
Key Resources
26
Capacity Building
24
Pharmacy & Technologies
18
Toolboxes
Malaria
114
AMR
39
Pharmacy
38
Ebola & Marburg
24
NTDs
21
HIV
15
Caregiver
10
TB
9
COVID-19
9
Rapid Response
8
Health Financing Toolbox
6
Mental Health
5
Planetary Health
5
Disability
4
Conflict
4
Refugee
3
2.0 Rapid Response
3
Global Health Education
3
Natural Hazards
2
Polio
2
Cholera
1
Zika
1
Scientists have known for more than half a century that patients could develop resistance to the drugs used to treat them. Alexander Fleming, who is credited with creating the first antibiotic, penicillin, in 1928, cautioned of the impending crisis while accepting his Nobel prize in 1945: “There ...
This Implementation Kit (I-Kit), developed by the Health Communication Capacity Collaborative (HC3), helps national and local stakeholders to design country-specific social and behavioural change communication (SBCC) campaigns that address the threat posed by substandard, spurious, falsified and fal...
The National Strategic Plan on Malaria Prevention and Elimination Period 2021 – 2025 seeks to build on the previous national successes of the National Institute of Malariology, Parasitology, and Entomology (NIMPE) while addressing current challenges to reduce the overall burden of malaria in the S...
Lymphatic filariasis is a neglected tropical disease that can cause permanent disability through disruption of the lymphatic system. This disease is caused by parasitic filarial worms that are transmitted by mosquitos. Mass drug administration (MDA) of antihelmintics is recommended by WHO to elimina...
Malar J (2017) 16:174 DOI 10.1186/s12936-017-1808-x
Background: Since 2004, artemisinin-based combination therapy (ACT) has been the first-line treatment for uncomplicated malaria in Benin. In 2016, a medicine outlet survey was implemented to investigate the availability, price, and market share of...
Antibiotics and other antimicrobial agents are invaluable life savers, particularly in resource-limited countries where infectious diseases are abundant. Both uncomplicated and severe infections are potentially curable as long as the aetiological agents are susceptible to the ...
Malaria is a prevalent cause of febrile illnesses in areas with high transmission, and its clinical presentation overlaps with initial signs of Ebola disease. For this reason, the effectiveness of the Ebola response in Guinea, Liberia and Sierra Leone can be optimized through the deployment of targe...
Review of International, Regional and National Policies and Legal Frameworks that Promote Migrants and Mobile Populations' Access to Health and Malaria Services in the Greater Mekong Subregion (Cambodia, Lao People's Democratic Republic, Myanmar, Thailand and Viet Nam)
Migrants and mobile popul...
Migrants and mobile popul...
In Kenya, the bacterial infections that contribute most to human disease are often those in which re-‐sistance is most evident. Examples are multidrug-‐resistant enteric bacterial pathogens such as typhoid, ...
The WHO guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-friendly and easy-to-navigate online platform.
The WHO guidelines for malaria bring together the Organization’s most up-to-date recommendations for malaria in one user-frie...
Spread of resistance to antimicrobial agents (AMR) does not know national borders and has reached dimensions, which require immediate actions at the national, regional and global levels.
Antibiotic resistance is a natural biological response to improper use of antimicrobial agents (AMA); increasing...
To mark the International Day of the African Child, Medicines for Malaria Venture (MMV) celebrated the inclusion of three of its antimalarial medicines on the WHO Model List of Essential Medicines (EML) and the EML for Children (EMLc). These are two artemisinin-based combination therapies (ACTs) for...
Fourth Edition
Ethiopia National Essential Medicine List
recommended
6 edition
Ethiopian Medicines Formulary
recommended
2nd edition
6th edition, 2010. | Published in collaboration with World Health Organisation and Clinton Health Access Initiative.
Accessed July 2014.
The essential medicines are those that meet the priority needs of the healthcare of the population. While reviewing the 5th edition of the essential Medicines, special attention focused on the health sector policy. Indeed, medicines play an important role in protecting, maintaining and restoring th...
The WHO Model List of Essential Medicines and Model List of Essential Medicines for Children are updated and published every two years, intended as a guide for countries or regional authorities to adopt or adapt in accordance with local priorities and treatment guidelines for the development and upd...
